Company Details
|
|
Address
|
York Biocentre, York Science Park, Innovation Way, Heslington, York, YO10 5NY
|
|
Telephone
|
0870 835 4367
|
|
Fax
|
0870 835 4368
|
Executives
|
|
Chairman
|
Gwynfor Humphreys (1.70% holding)
|
|
Chief Executive
|
Alastair Smith (6.00% holding)
|
|
Finance Director
|
Timothy Sykes (0.40% holding)
|
|
Chief Scientific Officer
|
Simon Webster (5.90% holding)
|
Main Shareholders
|
|
|
Robert Quested: 8.9% Kurt Baldwin: 5.9% Universities Superannuation Fund: 3.6% Christopher Potts: 3.2%
|
Advisers
|
|
Nominated Adviser
|
Daniel Stewart
|
|
Nominated Broker
|
Daniel Stewart
|
|
Solicitors
|
Walker Morris
|
|
Auditors
|
Baker Tilly
|
|
Registrar
|
Capita Registrars
|
|
Commentary
|
|
Develops detection and analysis technology and services aimed at the pharmaceutical, healthcare, security and industrial sectors
|
Company Data |
| Code |
AVCT |
| Sedol |
GB00335195 |
| Shares In Issue |
823.888 m |
| Indices
|
|
| Entry on AIM |
08/09/2003 |
| Interim Results |
Apr |
| Final Results |
Nov |
| Year End |
Jul |
| Accounts Due |
Jan |
| Int div payment |
n/a |
| Fin div payment |
n/a |
| Int net div per share |
nil |
| Fin net div per share |
nil |
| Probable CGT relief |
Yes |
| |
|
|